Promising news from DEA. DEA has now scheduled an inspection of Dr. Mithoefer’s facility on October 28, by agents from both the regional DEA office and the South Carolina Bureau of Drug Control. This is a routine step in the processing of a Schedule I license. It’s encouraging to see that DEA is finally moving forward with its responsibilities, now that IRB approval for the protocol has been obtained.